David Stump, M.D. ’72 served as Executive Vice President for Research and Development at Human Genome Sciences, Inc. from November 1999 until December 2012. From October 1995 to October 1999, he served as Vice President, Clinical Research and Genentech Fellow at Genentech, Inc. He first joined Genentech in 1989 as Director, Clinical Research and leader of its thrombolytic therapy drug development program. Prior to joining Genentech, he was Associate Professor of Medicine and Biochemistry at the University of Vermont. He received his medical degree at Indiana University and his postgraduate training at the University of Iowa as well as the University of Leuven, Belgium. He is board certified in Internal Medicine, Hematology and Medical Oncology and is a Fellow of the American College of Physicians and the Council on Arteriosclerosis, Thrombosis and Vascular Biology of the American Heart Association. He is the author of approximately 60 scientific publications, and is a member of the Board of Directors of Sunesis Pharmaceuticals, Inc., MacroGenics, Inc., Portola Pharmaceuticals, Inc., and Regenxbio, Inc. His late wife Carolyn Sorrows Stump ’71 served on the Alumni Council for nine years. David has served the Board for 10 years, nine years as Chair of its Academic Affairs Committee, and now as Board Chair.